Navigation Links
Study shows vitamin C is essential for plant growth
Date:9/23/2007

Scientists from the University of Exeter and Shimane University in Japan have proved for the first time that vitamin C is essential for plant growth. This discovery could have implications for agriculture and for the production of vitamin C dietary supplements.

The study, which is now published online in The Plant Journal, describes the newly-identified enzyme, GDP-L-galactose phosphorylase, which produces vitamin C, or ascorbate, in plants. Vitamin C is already known to be an antioxidant, which helps plants deal with stresses from drought to ozone and UV radiation, but until now it was not known that plants could not grow without it.

Professor Nicholas Smirnoff of the University of Exeter, lead author on the paper said: Vitamin C is the most abundant antioxidant in plants and yet its functions are poorly understood. By discovering that the new enzyme is encoded by two genes, we were able to engineer vitamin C-free plants and found that they were unable to grow.

The discovery also identifies the new enzyme as a key player in controlling vitamin C accumulation in response to light. Vitamin C provides protection against the harmful side-effects of light during photosynthesis, the process by which light energy is used to convert carbon dioxide into plant matter.

Professor Nicholas Smirnoff continued: The discovery is exciting for me because it is the culmination of a long-term research programme on vitamin C in plants at the University of Exeter. It opens new opportunities to understand fundamental growth processes in plants and to improve plant resistance to stresses in a changing climate. In the longer term I hope that it will contribute to the efforts of plant scientists to improve crop yield in a sustainable manner.

The findings could also pave the way for a new approach to producing vitamin C dietary supplements. In Britain we spend an estimated 20 million on vitamin C tablets each year, making this the most widely-used dietary supplement. Vitamin C is currently produced by mixed fermentation and chemical synthesis. The new enzyme provides the potential to engineer microbes to produce vitamin C by a simpler one-step process.


'/>"/>

Contact: Sarah Hoyle
s.hoyle@exeter.ac.uk
44-013-922-62062
University of Exeter
Source:Eurekalert

Related biology news :

1. Bioartificial kidney under study at MCG
2. Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down
3. W.M. Keck Foundation funds study of friendly microbes
4. Yellowstone microbes fueled by hydrogen, according to U. of Colorado study
5. Emory Study Tests Bone Marrow Stem Cells to Improve Circulation in Legs
6. UCLA Study Shows One-Third of Drug Ads in Medical Journals Do Not Contain References Supporting Medical Claims
7. Study Demonstrates Gene Expression Microarrays are Comparable and Reproducible
8. Study Links Ebola Outbreaks To Animal Carcasses
9. Genome-wide mouse study yields link to human leukemia
10. Breakthrough Microarray-based Technology for the Study of Cancer
11. NYU Study Reveals How Brains Immune System Fights Viral Encephalitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/6/2017)... 6, 2017 Forecasts by Product ... Readers, by End-Use (Transportation & Logistics, Government & Public ... & Fossil Generation Facility, Nuclear Power), Industrial, Retail, Business ... Are you looking for a definitive report on ... ...
(Date:4/5/2017)... Today HYPR Corp. , leading innovator ... of the HYPR platform is officially FIDO® Certified ... architecture that empowers biometric authentication across Fortune 500 enterprises ... over 15 million users across the financial services industry, ... product suites and physical access represent a growing portion ...
(Date:4/4/2017)... --  EyeLock LLC , a leader of iris-based identity ... and Trademark Office (USPTO) has issued U.S. Patent No. ... iris image with a face image acquired in sequence ... th issued patent. "The issuance ... multi-modal biometric capabilities that have recently come to market ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... ... prospective clinical study that demonstrates the accuracy of the FebriDx® test, a ... significant acute bacterial and viral respiratory tract infections by testing the body’s ...
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 ... overexpression experiments and avoiding the use of exogenous expression plasmids. The simplicity of ... performing systematic gain-of-function studies. , This complement to loss-of-function studies, such as ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. 11, ... Research, London (ICR) and University of ... SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma (MM), ... nine . The University of Leeds ... funded by Myeloma UK, and ICR will perform the testing ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... conjugate (ADC) therapeutics, today confirmed licensing rights that give it exclusive global ... technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). Additionally, ...
Breaking Biology Technology: